Navigation Links
NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
Date:3/11/2010

ROCKVILLE, Md., March 11 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer of Novavax will be presenting at the 22nd Annual ROTH OC Growth Stock Conference.  The presentation will take place on March 15, 2010 at 8:30 am pacific time at the Ritz Carlton, Laguna Niguel, California.  Dr. Singhvi will provide an overview of the company's business strategy, research and development progress and upcoming milestones.  A link to the live presentation can be accessed via the company website at www.novavax.com under the Investors tab.  An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

About Novavax, Inc.

Novavax, Inc. is a clinical-stage biotechnology company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology.  The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches.  Novavax is committed to using its VLP technology to create country-specific vaccine solutions.  The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: www.novavax.com.

SOURCE Novavax, Inc.

Back to top

RELATED LINKS
http://www.novavax.com

'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
2. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
3. Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
4. NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock
5. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
6. Novavax to Present at 8th Annual BIO Investor Forum 2009
7. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
8. NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
9. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
10. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
11. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... Research and Markets has ... Disposables Market 2016-2020"  report to their offering.  ... global anesthesia disposables market is set to ... the period 2016-2020.  Healthcare-acquired infections ... safety. Organizations like the CDC and Public ...
(Date:4/27/2016)... FRANCISCO , April 27, 2016 ... reach over USD 2.14 billion by 2022, according ... Inc.       (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ... technological advancement affecting the efficiency and accuracy delivered ... the persistent demand for novel urinalysis instruments and ...
(Date:4/27/2016)... April 27, 2016 At the ... launch of a Phase 2 clinical study of its ... patients undergoing cochlear implantation (CI) surgery. This large, placebo-controlled, ... Germany and France ... ear at the time of surgery. "Despite advances in ...
Breaking Medicine Technology:
(Date:4/28/2016)... , ... April 28, 2016 , ... ... today announced it will demonstrate its leading secure mobility workstation suite, SentinelSecure™, at ... Held at Hilton Union Square, this will be MobileIron’s 6th Mobile First Conference ...
(Date:4/28/2016)... ... April 28, 2016 , ... Denise McCormick Baich had written poetry dating back to her childhood, ... much like a tsunami and took on a more spiritual tone. The desire to put ... do more with it than just file it away. Friends would ask her how she ...
(Date:4/28/2016)... ... ... For the 10,000 Americans who turn 65 on any given day, “getting wiser” with ... Now, a new book—Staying Sharp For Dummies (Paper; ISBN: 978-1-119-18779-0; Available Now)—outlines simple things ... from honing your memory and managing stress to eating healthy foods as part of ...
(Date:4/28/2016)... Boston,MA (PRWEB) , ... April 28, 2016 , ... Boston ... U.S Food and Drug Administration (FDA). The treatment consists of the application of Riboflavin, ... of the collagen fibers which in turn strengthens the cornea to slow the progression ...
(Date:4/28/2016)... MA (PRWEB) , ... April 28, 2016 , ... The ... eating patterns based on the latest nutritional science. While there is a lot of ... improve their health, according to the April 2016 issue of Harvard Men's Health ...
Breaking Medicine News(10 mins):